PROVENTION BIO INC (PRVB) Stock News
NASDAQ:PRVB - Nasdaq - US74374N1028 - Common Stock - Currency: USD
PRVB Latest News, Press Relases and Analysis
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
Company Moves Ahead With Drug Development
Provention Bio gains after HSR waiting period for Sanofi deal expired (NASDAQ:PRVB)
Provention Bio (PRVB) rose 3.1% in premarket trading after the HSR antitrust waiting period for the company's sale to Sanofi (SNY) expired
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Tiziana Life Sciences (NASDAQ: TLSA), a London-based biotechnology company, is developing a first-in-class drug, Foralumab. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) at the clinical stage.
Is Sanofi Stock a Buy Now?
The pharma giant has outperformed the broader market over the past 12 months.
Mentions: SNY
Why Provention Bio Stock Skyrocketed 256% This Week
Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.
Mentions: SNY
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
A market rally is underway, but bank stocks kept tumbling.
Why Is First Republic Bank (FRC) Stock Down 61% Today?
First Republic Bank (FRC) stock is falling hard on Monday as bank stocks react to the recent drama surrounding SVB Financial (SIVB).
Why Is Science 37 (SNCE) Stock Up 9% Today?
Science 37 (SNCE) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees.
Mentions: SNCE
Shareholder Alert: Ademi LLP investigates whether Provention Bio, Inc. has obtained a Fair Price in its transaction with Sanofi
/PRNewswire/ -- Ademi LLP is investigating Provention Bio (Nasdaq: PRVB) for possible breaches of fiduciary duty and other violations of law in its transaction...
Why Is Provention Bio (PRVB) Stock Up 263% Today?
Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.
Mentions: SNY
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PRVB, SGEN, XM
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Hot Stocks: ZIM, ZYXI rise; PRVB, SGEN jumps on M&A deal; ILMN, up; ZEV, FRC, SCHW slide
Stocks see-sawed during Monday#39;s intraday trading as investors weighed a proposal to backup all of the depositors in the defunct Silicon Valley Bank.Looking at the specific stocks that...
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
Pfizer expects Seagen to add at least $10 billion to its topline in 2030.
PRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholders
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday!